Addex Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Addex Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Addex Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Addex Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Addex Therapeutics Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022272005A1 | Application | Substituted heterobicyclic derivatives as negative allosteric modulators of mglu7 receptor | A61P25/00; C07D237/32; C07D401/04; C07D401/14; C07D403/04; C07D403/10; C07D403/14; C07D405/04; C07D491/08 | November 16, 2023 |
| AU2022275120A1 | Application | Fused heterocyclic derivatives as negative allosteric modulators of mglu7 receptor | A61P25/00; C07D487/04 | November 16, 2023 |
| GB202216963D0 | Application | Novel compounds | A61P25/00; A61P27/16; C07D487/04 | December 28, 2022 |
| GB202216962D0 | Application | Novel compounds | A61P25/00; A61P27/16; C07D487/04 | December 28, 2022 |
| GB202216960D0 | Application | Novel compounds | A61P25/00; A61P27/16; C07D471/04 | December 28, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer